Hepatobiliary cancers

Al B. Benson; Thomas A. Abrams; Edgar Ben-Josef; P. Mark Bloomston; Jean F. Botha; Bryan M. Clary; Anne Covey; Steven A. Curley; Michael I. D'Angelica; Rene Davila; William D. Ensminger; John F. Gibbs; Daniel Laheru; Mokenge P. Malafa; Jorge Marrero; Steven G. Meranze; Sean J. Mulvihill; James O. Park; James A. Posey; Jasgit Sachdev; Riad Salem; Elin R. Sigurdson; Constantinos Sofocleous; Jean Nicholas Vauthey; Alan P. Venook; Laura Williams Goff; Yun Yen; Andrew X. Zhu

doi:10.6004/jnccn.2009.0027

Hepatobiliary cancers

Al B. Benson
, Thomas A. Abrams
, Edgar Ben-Josef
, P. Mark Bloomston
, Jean F. Botha
, Bryan M. Clary
, Anne Covey
, Steven A. Curley
, Michael I. D'Angelica
, Rene Davila
, William D. Ensminger
, John F. Gibbs
, Daniel Laheru
, Mokenge P. Malafa
, Jorge Marrero
, Steven G. Meranze
, Sean J. Mulvihill
, James O. Park
, James A. Posey
, Jasgit Sachdev

Riad Salem, Elin R. Sigurdson, Constantinos Sofocleous, Jean Nicholas Vauthey, Alan P. Venook, Laura Williams Goff, Yun Yen, Andrew X. Zhu

Research output: Contribution to journal › Review article › peer-review

48 Citations (Scopus)

Abstract

Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.

Original language	English
Pages (from-to)	350-351+366-390
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	7
Issue number	4
DOIs	https://doi.org/10.6004/jnccn.2009.0027
Publication status	Published - Apr 2009
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Biologic therapy
Chemoembolization
Chemotherapy
Cholangiocarcinomas
Cirrhosis
Gallbladder cancer
Hepatitis
Hepatocellular carcinoma
NCCN Clinical practice Guidelines
Surgical resection
Transplantation
Tumor ablation

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2009.0027

Cite this

Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., Ensminger, W. D., Gibbs, J. F., Laheru, D., Malafa, M. P., Marrero, J., Meranze, S. G., Mulvihill, S. J., Park, J. O., Posey, J. A., ... Zhu, A. X. (2009). Hepatobiliary cancers. JNCCN Journal of the National Comprehensive Cancer Network, 7(4), 350-351+366-390. https://doi.org/10.6004/jnccn.2009.0027

Benson, AB, Abrams, TA, Ben-Josef, E, Bloomston, PM, Botha, JF, Clary, BM, Covey, A, Curley, SA, D'Angelica, MI, Davila, R, Ensminger, WD, Gibbs, JF, Laheru, D, Malafa, MP, Marrero, J, Meranze, SG, Mulvihill, SJ, Park, JO, Posey, JA, Sachdev, J, Salem, R, Sigurdson, ER, Sofocleous, C, Vauthey, JN, Venook, AP, Goff, LW, Yen, Y & Zhu, AX 2009, 'Hepatobiliary cancers', JNCCN Journal of the National Comprehensive Cancer Network, vol. 7, no. 4, pp. 350-351+366-390. https://doi.org/10.6004/jnccn.2009.0027

@article{9cc8cedb932d4a79a1cd2a12cf250481,

title = "Hepatobiliary cancers",

abstract = "Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.",

keywords = "Biologic therapy, Chemoembolization, Chemotherapy, Cholangiocarcinomas, Cirrhosis, Gallbladder cancer, Hepatitis, Hepatocellular carcinoma, NCCN Clinical practice Guidelines, Surgical resection, Transplantation, Tumor ablation",

author = "Benson, \{Al B.\} and Abrams, \{Thomas A.\} and Edgar Ben-Josef and Bloomston, \{P. Mark\} and Botha, \{Jean F.\} and Clary, \{Bryan M.\} and Anne Covey and Curley, \{Steven A.\} and D'Angelica, \{Michael I.\} and Rene Davila and Ensminger, \{William D.\} and Gibbs, \{John F.\} and Daniel Laheru and Malafa, \{Mokenge P.\} and Jorge Marrero and Meranze, \{Steven G.\} and Mulvihill, \{Sean J.\} and Park, \{James O.\} and Posey, \{James A.\} and Jasgit Sachdev and Riad Salem and Sigurdson, \{Elin R.\} and Constantinos Sofocleous and Vauthey, \{Jean Nicholas\} and Venook, \{Alan P.\} and Goff, \{Laura Williams\} and Yun Yen and Zhu, \{Andrew X.\}",

year = "2009",

month = apr,

doi = "10.6004/jnccn.2009.0027",

language = "English",

volume = "7",

pages = "350--351+366--390",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "4",

}

TY - JOUR

T1 - Hepatobiliary cancers

AU - Benson, Al B.

AU - Abrams, Thomas A.

AU - Ben-Josef, Edgar

AU - Bloomston, P. Mark

AU - Botha, Jean F.

AU - Clary, Bryan M.

AU - Covey, Anne

AU - Curley, Steven A.

AU - D'Angelica, Michael I.

AU - Davila, Rene

AU - Ensminger, William D.

AU - Gibbs, John F.

AU - Laheru, Daniel

AU - Malafa, Mokenge P.

AU - Marrero, Jorge

AU - Meranze, Steven G.

AU - Mulvihill, Sean J.

AU - Park, James O.

AU - Posey, James A.

AU - Sachdev, Jasgit

AU - Salem, Riad

AU - Sigurdson, Elin R.

AU - Sofocleous, Constantinos

AU - Vauthey, Jean Nicholas

AU - Venook, Alan P.

AU - Goff, Laura Williams

AU - Yen, Yun

AU - Zhu, Andrew X.

PY - 2009/4

Y1 - 2009/4

N2 - Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.

AB - Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.

KW - Biologic therapy

KW - Chemoembolization

KW - Chemotherapy

KW - Cholangiocarcinomas

KW - Cirrhosis

KW - Gallbladder cancer

KW - Hepatitis

KW - Hepatocellular carcinoma

KW - NCCN Clinical practice Guidelines

KW - Surgical resection

KW - Transplantation

KW - Tumor ablation

UR - https://www.scopus.com/pages/publications/65349184115

UR - https://www.scopus.com/pages/publications/65349184115#tab=citedBy

U2 - 10.6004/jnccn.2009.0027

DO - 10.6004/jnccn.2009.0027

M3 - Review article

AN - SCOPUS:65349184115

SN - 1540-1405

VL - 7

SP - 350-351+366-390

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 4

ER -

Hepatobiliary cancers

Abstract

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this